ESHELMAN FREDRIC N 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-21 4:30 pm Purchase | 2022-11-18 | 13D | G1 Therapeutics, Inc. GTHX | ESHELMAN FREDRIC N | 4,766,074 9.260% | 1,072,479 (+29.04%) | Filing |